Scientists say a new study into weight loss drugs like Mounjaro, Wegovy and Ozempiccan suggest the impact of GLP-1 medicines "may reach further and transform how we think about cancer prevention"

The potential benefits of GLP-1 drugs, like Ozempic or Wegovy, are stacking up.

Una serie de nuevas investigaciones muestran que los fármacos GLP-1, como Ozempic, Wegovy y Mounjaro, podrían tener efectos positivos sobre el cáncer y mejorar los síntomas de la…

Experts from the US examined data on more than 161,000 patients

Scientists say a new study into weight loss drugs like Mounjaro, Wegovy and Ozempiccan suggest the impact of GLP-1 medicines "may reach further and transform how we think about…

A major new study looks at thousands of people taking the medication

Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.Jump to contentThank you for registeringPlease refresh the page or…

A new wave of research links GLP-1 drugs to reduced cancer spread and better survival, and the mechanism may go beyond just weight loss

Trabalho analisou dados de milhares de pacientes que receberam Ozempic, Wegovy e Mounjaro ao longo de dois anos

Trial suggests monoclonal antibody can help retain lean body mass when losing weight with GLP-1 medicines

GLP-1s may be able to alter the body’s inflammatory and metabolic environment making cancer therapies more effective. Clinical trials will be the next step.

With great scientific discoveries come great dilemmas. And one such dilemma that dominates the medical zeitgeist relates to weight-loss injections such as Wegovy, Ozempic and…